Serum values (normal values) | Group I (Cases) (n = 69) | Group II (Controls) (n = 50) | P value |
---|---|---|---|
Conjugated Bilirubin (μmol /L) (<  3.4 μmol/L) [median, IQR] | 70.1 (129.9) (1.7–205.2) | 1.71 (0.34) (1.7–3.4) | < 0.001 |
Total Bilirubin (μmol /L) (<  21 μmol/L) [median, IQR] | 111.5 (181.3) (1.7–388.3) | 8.55 (3.42) (5.1–13.7) | < 0.001 |
AST (U/L) (<  1 year (15–60); 1–3 years (20–60); 4–6 years (15–50) [median, IQR] | 117 (130.5) (19–831) | 29.5 (16.25) (18–48) | < 0.001 |
ALT (U/L) (13–45) [median, IQR] | 72 (96) (14–472) | 23 (10) (10–44) | < 0.001 |
GGT (U/L) [<  1 year boy (5–65); <  1 year girl (5–35); 1–5 years (0–23)] [median, IQR] | 261 (531.5) (12–2164) | 13 (12.25) (5–32) | < 0.001 |
ALP (U/L) [<  2 years (150–40);2–10 years (100–320)] [median, IQR] | 461 (437.5) (79–1925) | 194 (77) (147–403) | < 0.001 |
Albumin (μmol/L) [4–6 months (2.8–5); 7–12 months (3.2–5.7); 13–24 months (1.9–5); 25–36 months (3.3–5.8); 3–5 years (2.9–5.8)] [mean ± SD] | 3.4 ± 0.8 (1.6–5) | 4.2 ± 0.7 (3–5.5) | < 0.001 |
Prothrombin time (seconds) [<  1 year [13 (10.1–15.9); 1–5 years (11 (10.6–11.4)] [mean ± SD] | 15.3 ± 3.5 (13–32) | 12.9 ± 0.5 (12–13.9) | < 0.001 |
IGF-1(nmol/L) (2.22–37.13) [median, IQR] | 3.14 (1.38) (1.78–5.09) | 5.22 (0.99) (4.31–6.93) | < 0.001 |
25 (OH) D (nmol/L) (42.43–134.7) [mean ± SD] | 63 ± 13.25 (33.25–98.5) | 59.75 ± 9 (64.75–152.5) | < 0.001 |
INR [1 (0.96–1.04)] [mean ± SD] | 1.2 ± 0.4 (1–3.2) | 1 | < 0.001 |
Hemoglobin (g/dl) [6 months-2 years (12); 2–6 years (12.5)] | 10.1 ± 0.15 (6.7–14.1) | 11.9 ± 1.4 (9.6–14.5) | < 0.001 |
Total leucocytic count (× 103/μL) [6 months-2 years (8.5 (5–15.5); 2–6 years (8.1 (4.5–13.5)] [mean ± SD] | 11.5 ± 4.7 (3.5–25) | 10.5 ± 4.1 (4.8–14) | 0.229 |
Platelets (× 103/μL) [mean ± SD] [6 months-6 years (150–350)] | 342.3 ± 194.1 (15–964) | 279.1 ± 135.5 (190–856) | 0.050 |